The therapies are poised to revolutionize the cancer care landscape, but it will require collaboration across the industry, ...

Theranostics is an advanced approach to cancer diagnosis and treatment that combines therapeutics and diagnostics into an ...

Established in 2022, the Lancet Oncology Commission on Radiotherapy and Theranostics was led by the IAEA and includes experts from 44 academic institutions and medical centres across 23 different ...

In 2016, Dr. Calais joined the theranostics team at UCLA. The researchers joined forces with a team at UCSF to develop an imaging technique for diagnosing prostate cancer at the whole-body level ...

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...

Elucida Oncology is developing ultrasmall (10 nm) hybrid silica particles, C'-Dots, for guiding highly targeted image-directed surgical treatment and/or efficient delivery of small-molecule ...

the increasing focus on precision oncology continued apace. Here, Professor Marie-Laure Yaspo, Chief Scientific Officer at Alacris Theranostics, discusses her work on molecular tumour profiling, ...

Nuclear medicine and radiation oncology are evolving within modern ... therapeutic applications has contributed to developments in Theranostics, a field that combines diagnosis and therapy to ...

For Andreas Dreps, ICON’s senior vice president, oncology drug development, many of the most exciting developments in oncology are in the area of cell and gene therapy. • Read the full article ...